Apple, Mylan lose US SC bids to challenge patent review rule Dr. Divya Colin23 Jan 2022 3:00 PM ISTNew Delhi: The U.S. Supreme Court on Tuesday turned back challenges by Apple Inc and drugmaker Mylan Laboratories Ltd to a rule change that made it...
Biocon, Viatris application for Insulin Aspart rejected by USFDA Ruchika Sharma11 Jan 2022 3:30 PM ISTNew Delhi: Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for...
Health Bulletin 3/January/2022 Dr. Nandita Mohan3 Jan 2022 7:45 PM ISTHere are the Top Health stories of the dayIndia's Omicron count crosses 1,700-markNMC nod to DM cardiology course at PGIMS RohtakIn a major milestone...
Alembic Pharma gets USFDA nod for Formoterol Fumarate Inhalation Solution Ruchika Sharma23 Nov 2021 12:52 PM ISTMumbai: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received final approval from the US Food &...
Mylan gets CDSCO panel nod to import, market Cutaneous Cryogenic Spray of Endwarts Freeze Medical Dialogues Team26 Sept 2021 11:00 AM ISTNew Delhi: Mylan Pharmaceuticals has received approval from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Setback: Mylan proposal for Hydroxychloroquine Sulfate Tablet rejected by CDSCO panel Medical Dialogues Team6 Aug 2021 1:02 PM ISTNew Delhi: In a major setback to Mylan Laboratories, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
Pfizer to pay over Rs 2574 crore to resolve EpiPen pricing lawsuit Ruchika Sharma18 July 2021 12:00 PM ISTNew Delhi: Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who say they overpaid for EpiPens due to anticompetitive...
EpiPen Antitrust Case: Sanofi likely to take Mylan to court again Medical Dialogues Team14 Jun 2021 6:12 PM ISTNew Delhi: Challenging the district court's erroneous ruling in a case against pharmaceutical giant Mylan, Sanofi, the French multinational...
Cipla, Mylan, others directed to allocate Remdesivir to states, UTs as per Govt supply plan Medical Dialogues Team9 May 2021 11:15 AM ISTNew Delhi: In continuation of the allocation plan of Remdesivir drug for the period 21st April to 9th May, the Ministry of Health and Family Welfare...
Prices of Remdesivir slashed, now as cheap as Rs 899, says NPPA Farhat Nasim18 April 2021 11:03 AM ISTNew Delhi: Through a recent office memorandum, National Pharmaceutical Pricing Authority (NPPA) has announced a reduction in the price of seven brands...
Govt directs Sun Pharma, Cipla, 5 others to ramp up Covid drug remdesivir production to full capacity Ruchika Sharma8 April 2021 5:03 PM ISTMandaviya said these seven manufacturers- Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy''s, Zydus Cadila and Sun Pharma - have a monthly...
NPPA Fixes Retail Price Of 41 Formulations; Details Medical Dialogues Team19 March 2021 1:44 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
